Bayer contract aids Probitas expansion
Grifols has signed an agreement with the Biological Products
division at Bayer Healthcare in the USA to supply pharmaceutical
Nanotechnology advisory group set up in UK
A UK programme aimed at identifying the environmental, health and
safety, ethical and societal implications of nanotechnology has
appointed a working group to oversee the effort.
Biotech merger wave gathers up KS Bio
KS Biomedix has confirmed that it is in negotiations that may lead
to a merger and add to the mini-wave of consolidation sweeping over
the UK industry.
Budget tablet press launched in UK
Isopak of the UK has introduced a single punch benchtop tablet
press machine that is designed to answer the needs of small
laboratories, pharmacies and hospitals.
Argonaut exits HPLC business
Argonaut sells its HPLC business to Grace Vydac as it refocuses on
supplying consumables for companies working on drug discovery.
Reports reduced losses in first half.
Degussa buys into "designer" solvents
Degussa has acquired a stake in a company specialising in ionic
liquids, an innovative technology that could provide a greener
alternative to commonly used volatile organic solvents in the
manufacture of pharmaceuticals.
New team in protein separation
Alfa Laval and Millipore are to work together to supply tools for
the recovery of biopharmaceutical proteins generated by cell
culture and fermentation.
Amersham comes in low, but on track
Amersham trims its 2003 profit outlook again after reporting lower
interim sales and profits, but points to currency effects and the
underlying strength of the business
Roche buys its way out of diagnostics trouble
Roche has moved to settle its long-running legal dispute with
USA-based Igen by acquiring the firm in a deal valued at around
$1.4 billion (€1.22bn).
Pliva opens new unit in USA
Pliva has continued its rapid expansion with the opening of a new
R&D facility in the USA that will carry out formulation work on
Funguard capacity to swell on sales growth
Fujisawa has decided to build a new formulation plant for its
recently launched antifungal Funguard with a capital investment of
Y3.8 billion (€28m).
Chemical ID for high-value products
Vencor has launched a range of chemical taggants that can be used
to provide secure identification of products, including drugs and
Pharma holds back life sciences at DSM
DSM reports a disappointing set of second quarter results and says
it is unlikely to meet its 2002 operating profit level this year;
the group blames weaker demand for its products and negative
currency factors. Restructuring drive...
Sweet way to protein production
Scientists have developed a way of making proteins in sugarcane
that they claim will be safe and less expensive than transgenic
approaches using animals.
Baxter wins court order in Bayer espionage case
A judge has ordered an employee at Bayer's US subsidiary to hand
files over to the court in a lawsuit brought by Baxter alleging